
Agilent Technologies A
€ 117.27
-0.02%
Quartalsbericht 2025-Q2
hinzugefügt 29.08.2025
Agilent Technologies Kurshistorie 2011-2025 | A
Kurshistorie Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 139 | 119 | 81.2 | 74.1 | 70.9 | 46.8 | 35.6 | 35.4 | 38.6 | 29.4 | 27.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 139 | 27.7 | 63.4 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 19.34 | -1.5 % | $ 99.4 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 20.94 | -3.81 % | $ 225 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.54 | 0.65 % | $ 1.96 M | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 10.07 | -0.69 % | $ 286 M | ||
|
DexCom
DXCM
|
126 | $ 67.38 | 0.78 % | $ 26 B | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 39.95 | -0.62 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Exact Sciences Corporation
EXAS
|
50.3 | $ 101.55 | -0.04 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
208 | $ 231.43 | 0.25 % | $ 169 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 27.07 | -0.33 % | $ 818 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
9.69 | $ 19.74 | -1.4 % | $ 1.06 B | ||
|
Celcuity
CELC
|
10.1 | $ 101.86 | -0.48 % | $ 4.02 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
2.22 | $ 3.37 | 2.12 % | $ 107 K | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 0.24 | -2.12 % | $ 7.04 M | ||
|
IQVIA Holdings
IQV
|
197 | $ 225.99 | 0.34 % | $ 41 B | ||
|
Guardant Health
GH
|
47.6 | $ 102.76 | 0.25 % | $ 12.6 B | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
1.41 K | $ 1 418.87 | 0.3 % | $ 30.1 B | ||
|
Illumina
ILMN
|
103 | $ 135.59 | -0.44 % | $ 21.6 B | ||
|
Charles River Laboratories International
CRL
|
166 | $ 203.03 | 0.04 % | $ 10.4 B | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 5.07 | -0.61 % | $ 2.72 M | ||
|
NeoGenomics
NEO
|
12.1 | $ 12.25 | -1.41 % | $ 1.55 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 7.1 | -0.77 % | $ 1.54 B | ||
|
Quotient Limited
QTNT
|
2.59 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
172 | $ 176.04 | 0.52 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
0.71 | $ 6.65 | -1.48 % | $ 862 M | ||
|
Myriad Genetics
MYGN
|
10.7 | $ 6.5 | -0.99 % | $ 589 M | ||
|
Laboratory Corporation of America Holdings
LH
|
252 | $ 254.52 | 0.57 % | $ 21.4 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 183.34 | 0.15 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
457 | $ 685.01 | 0.4 % | $ 56.5 B | ||
|
Pacific Biosciences of California
PACB
|
5.57 | $ 1.86 | 2.2 % | $ 472 M | ||
|
Lantheus Holdings
LNTH
|
93.4 | $ 66.88 | 0.53 % | $ 4.63 B | ||
|
Biomerica
BMRA
|
3.13 | $ 2.62 | - | $ 6.02 M | ||
|
Bioventus
BVS
|
5.6 | $ 7.4 | -1.79 % | $ 464 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M |